Invention Grant
- Patent Title: Transmucosal ketamine delivery composition
-
Application No.: US15148106Application Date: 2016-05-06
-
Publication No.: US10172810B2Publication Date: 2019-01-08
- Inventor: John A. McCarty
- Applicant: PHARMACEUTICAL PRODUCTIONS INC.
- Applicant Address: US FL Miami Springs
- Assignee: Pharmaceutical Productions, Inc.
- Current Assignee: Pharmaceutical Productions, Inc.
- Current Assignee Address: US FL Miami Springs
- Agency: Foley Hoag LLP
- Main IPC: A61K31/135
- IPC: A61K31/135 ; A61K47/48 ; A61K47/26 ; A61K47/14 ; A61K9/00 ; A61K47/38 ; A61K9/20 ; A61K9/08 ; A61K47/12 ; A61K47/36 ; A61K31/465 ; A61K47/54

Abstract:
Disclosed are preparations and formulations of high thermodynamic activity lipophilic associations (LA), in which there is pairing between an ionizable pharmaceutical agent and a lipophilic species having ionic characteristics opposite to that of the pharmaceutical agent. Such lipophilic associations manifest high thermodynamic activity, as evidenced by their being predominantly in a liquid phase at room temperature or solvated in a lower-than-water dielectric solvent. Further the pharmaceutical agent being solubilized means that dissolution is not rate limiting to transmucosal absorption. This LA or LA-solvate is formulated into a low dielectric dosage form, from when, upon the dosage form's hydration, the pharmaceutical agent is driven through the mucosal tissue and into systemic circulation. The invention therefore provides an enhanced transmucosal drug delivery system for ionizable pharmaceutical agents at or near physiological pH.
Public/Granted literature
- US20160256415A1 TRANSMUCOSAL KETAMINE DELIVERY COMPOSITION Public/Granted day:2016-09-08
Information query